Imprimis Pharmaceuticals, Inc.
Imprimis Pharmaceuticals, Inc. (IMMY) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 67 transactions totaling $5.2M, demonstrating a bearish sentiment with -$2.5M in net insider flow. The most recent transaction on Dec 3, 2018 involved a sale of 10,000 shares valued at $46.4K.
IMMY Insider Activity Summary
Who Is Buying IMMY Stock?
No significant insider buying has been recorded for IMMY in the recent period.
Who Is Selling IMMY Stock?
No significant insider selling has been recorded for IMMY in the recent period.
Is Imprimis Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for IMMY is bearish with an Insider Alignment Score of 26/100 and a net flow of -$2.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
IMMY Frequently Asked Questions
Understanding IMMY Insider Activity
Insider trading at Imprimis Pharmaceuticals, Inc. (IMMY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading IMMY stock, having executed 67 transactions in the past 90 days. The most active insider is Donald Paul Miloni (Executive), who has made 2 transactions totaling $3.3M.
Related Tools
Track Imprimis Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at IMMY file new Form 4 transactions